abstract |
The invention relates to compounds of formula (I) wherein the substituents are described in claim 1. The compounds can be used in the treatment of diseases based on the glycine uptake inhibitor, such as psychosis, pain, neurodegenerative dysfunction with regard to memory and learning, schizophrenia, dementia and other diseases where cognitive processes are impaired, such as attention deficit disorders or Alzheimer's disease. |